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ABSTRACT
Preeclampsia is one of the main causes of maternal and perinatal mortality and morbidity. 
The pathogenesis of preeclampsia remains unclear until now. It is believed that regulation 
of apoptosis in trophoblast cells plays an important role in the pathophysiology of 
preeclampsia. Failure of spiral arteries remodeling will eventually lead to placental hypoxia 
lead to excessive trophoblast apoptosis. The molecular mechanism of apoptosis is very 
complicated involving many signaling molecules included Bcl-2 proteins. The Bcl-2 
protein group consists of proapoptosis proteins (Bax) and apoptosis inhibitor proteins 
(Bcl-2 and Bcl-xL). The aimed of this stuty was to compare the expression of Bcl-xL 
protein in placental trophoblast cells of pregnancy complicated by severe preeclampsia 
with that normotensive pregnancy. This study was an observational study with cross 
sectional design involving 43 pregnancy patients with severe preeclampsia and 38 
normotensive pregnancy who treated in Dr. Sardjito General Hospital, Yogyakarta from 
October 2011 until March 2012. Placenta samples were obtained from all subjects for 
Bcl-xL protein expression analysis using immunohistochemistry technique. Data were 
analyzed using independent t-test, chi-square test, and logistic regression. A p value 
<0.05 was considered significant. Significant difference in Bcl-xL protein expression 
in trophoblast cells of pregnancy complicated by severe preeclampsia (1.29 ± 0.12) 
compared to that normotensive pregnancy (1.71 ± 0.14) was reported (p = 0.00). In 
addition, logistic regression test showed that diagnosis of severe preeclampsia had a 
statistically significant role in Bcl-xL protein expression (p= 0.000). In conclusion, the 
expression of Bcl-xL protein is lower in pregnancy complicated by severe preeclampsia 
compared to normotensive pregnancy.
ABSTRAK
Preeklamsia merupakan salah satu penyebab utama mortalitas dan morbiditas maternal 
dan perinatal. Patogenesis preeklamsia masih belum jelas sampai saat ini. Diduga 
pengaturan apoptosis pada sel trofoblas memegang peranan penting dalam patofisiologi 
preeklamsia. Kegagalan remodeling arteri spiralis akan menyebabkan hipoksia pada 
plasenta dan apoptosis trofoblas yang berlebihan. Mekanisme molekuler apoptosis sangat 
komplek yang melibatkan banyak molekul sinyal termasuk protein Bcl-2. Kelompok protein 
Bcl-2 terdiri dari protrin proapoptosis (Bax) dan penghambat apoptosis (Bcl-2 dan Bcl-
xL). Penelitian ini bertujuan untuk membandingkan ekspresi protein Bcl-xL sel trofoblas 
plasenta pada kehamilan dengan preeklamsia berat dengan kehamilan nomal. Penelitian 
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INTRODUCTION
Preeclampsia is one of the main causes of 
maternal and perinatal mortality and morbidity. 
The pathogenesis of preeclampsia remains 
unclear until now. However, it is believed 
that the failure of spiral arteries remodeling 
will eventually leads to placental hypoxia. 
This theory may not be the main cause of 
preeclampsia, but at least it is involved in the 
pathogenesis of this disease.1, 2
Apoptosis has an important role not only 
in the development of placenta but also in the 
pathophysiology of pregnancy complicated by 
preeclampsia. Apoptosis of trophoblast cells 
is increasing with gestational age and this 
increase has been studied as a complication of 
pregnancy with preeclampsia and intrauterine 
growth restriction (IUGR). Although this 
hypothesis is still under study, it is believed 
that regulation of apoptosis in trophoblast 
cells plays a key role in the pathophysiology 
of preeclampsia.3, 4
The molecular mechanism of apoptosis 
in human is very complicated involving 
many signaling molecules included Bcl-2 
proteins. The Bcl-2 protein family consists 
of proapoptotic protein such as Bak and Bax, 
and apoptosis inhibitor protein such as Bcl-2 
and Bcl-xL. During pregnancy, Bcl-2 is found 
in placenta since first trimester of pregnancy 
until third trimester and the concentration is 
decreasing with gestational age. In pregnancy 
complicated by preeclampsia, regulators 
of placental apoptosis are expressed 
differently. Several recent studies have 
found that expression of Bcl-2 and Bcl-xL 
as antiapoptotic molecules in patients with 
severe preeclampsia and IUGR are lower than 
patients with normal pregnancy.3, 4
The purpose of this study was to compare 
the expression of Bcl-xL protein in placental 
trophoblast cells of pregnancy complicated 
by severe preeclampsia with normotensive 
pregnancy. This study also aimed to evaluate 
the effect of maternal age, gestational age, and 
maternal mean arterial pressure (MAP) in the 
expression of Bcl-xL protein.
MATERIALS AND METHODS
Subjects
This was an observational study with cross 
sectional design. The population were patients 
with severe preeclampsia and normotensive 
patients who treated in Dr. Sardjito General 
Hospital, Yogyakarta, Indonesia from October 
2011 until March 2012. The inclusion criteria 
observasi dengan rancangan potong lintang ini melibatkan 43 pasien wanita hamil dengan 
preeklamsia berat dan 38 wanita hamil normotensi yang dirawat di RSUP Dr. Sardjito, 
Yogyakarta antara Oktober 2011 sampai Maret 2012. Sampel plasenta diambil dari semua 
subjek untuk pemeriksaan ekspresi protein Bcl-xL menggunakan teknik imunohistokimia. 
Data yang diperoleh dianalisis denga uji t independen, uji chi square dan uji regresi logistic. 
Nilai p<0.05 digunakan sebagai dasar menyatakan perbedaan nyata. Dijumpai perbedaan 
nyata ekspresi protein Bcl-xL pada sel trofoblas kehamilan dengan preeklamsia berat (1,29 
± 0,12) dibandingkan dengan kehamilan normotensi (1,71 ± 0,14) (p=0,00). Selain itu, 
uji regresi logistik menunjukkan diagnosis preeklamsia berat mempengaruhi secara nyata 
terhadap ekspresi protein Bcl-xL (p=0,000). Dapat disimpulkan bahwa ekspresi protein 
Bcl-xL lebih rendah pada kehamilan dengan preeklamsia berat dibandingkan dengan 
kehamilan normotensi.
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were patients with severe preeclampsia in 28-
40 weeks of gestational age and agreed to be 
included in the study. The exclusion criteria 
were presence of comorbid diseases such 
as chorioamnionitis, chronic hypertension, 
diabetes, systemic lupus erythematosus, sickle 
cell disease, thyroid diseases, heart diseases, 
bronchial asthma, seizure which was caused 
by other etiologies beside preeclampsia, HIV, 
and fetus with major congenital disorder. 
Written inform consent were obtained from 
each patient after sufficient information was 
given. 
Protocol of study
Samples were taken from the placenta 
immediately after the baby was born. Samples 
were then sent to Histology Laboratory, 
Faculty of Medicine, Universitas Gadjah 
Mada, Yogyakarta, Indonesia. Samples 
of placental tissue were stained using 
immunohistochemistry technique to measure 
the expression of Bcl-xL protein. The 
expression of Bcl-xL protein was reported to be 
positive if brown color was found in cytoplasm 
or cell membrane. The expression of Bcl-xL 
protein was measured using semiquantitative 
immunohistochemical scoring system 
(HSCORE). The formula was HSCORE = 
∑ Pi (i+1), where Pi was percentage of cells 
which are stained positively with Bcl-xL 
immunostaining and i was intensity of staining 
with different grades (0=negative; 1=weakly 
positive; 2=moderately positive; 3=strongly 
positive). The HSCORE measurement was 
conducted by two observers with concealment 
of sample’s identity. Inter observer agreement 
was tested using kappa test and the result 
of kappa value was 0.88 which showed that 
there was a strong agreement between two 
observers. Expression of Bcl-xL was observed 
with microscop using high magnification 
(400x) in 5 fields of view from each samples. 
The protocol of the study was approved by 
the Medical and Health Research Ethics 
Committee, Faculty of Medicine, Universitas 
Gadjah Mada, Yogyakarta.
Statistical analysis
All numerical data were presented as mean 
± standard deviation (SD). Statistical analysis 
was conducted using independent t test to 
evaluate the difference in mean between two 
groups. Bivariate analysis using chi-square test 
was used to evaluate correlation between two 
categorical variables. Multivariate analysis 
using logistic regression was applied to 
evaluate the relationship between independent 
variable (preeclamptic vs normotensive 
group), confounding variables (patient’s age, 
gestational age, and mean arterial pressure), 
and dependent variable (Bcl-xL protein 
expression). A p value less than 0.05 was 
considered statistically significant.
RESULTS
Placenta samples were obtained from 
43 patients with pregnancy complicated by 
severe preeclampsia and 38 patients with 
normotensive pregnancy. All samples were 
stained using immunohistochemistry technique 
to evaluate the expression of Bcl-xL protein 
Characteristics of subjects of normotensive 
and severe preeclamptic groups are shown 
in TABLE 1. No significantly different of 
patient’s age of severe preeclamptic compared 
to normotensive group was observed (p>0.05). 
Meanwhile, there were significant differences 
of gestational age and MAP of both groups 
(p<0.05). 
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TABLE 1. Characteristics of subjects (mean ± SD) of normotensive and severe preeclamptic groups
Variable Normotensive Group (n=38)
Severe Preeclamptic 
Group (n=43)
Mean Difference 
(95% CI) p
Patient’s age (years) 
Gestational age (weeks) 
Mean arterial pressure (mmHg)
28.42 ± 6.77 
35.67 ± 3.01 
126.29 ± 17.00
28.37 ± 7.08 
38.39 ± 1.85 
88.95 ± 6.44
0.5 (-3.0136 – 3.116) 
-2.72(-3.82 - -1.63) 
37.34 (31.74-42.94)
0.974 
0.000 
0.000
In this study, the expression of Bcl-xL 
protein was observed in decidual trophoblast. 
In accordance with early onset preeclampsia 
theory which stated that the failure of spiral 
artery remodelling occured in decidual 
FIGURE 1. Intensity of color in Bcl-xL protein staining
layer. The change in intensity of brown 
color in trophoblast cells of decidual layer 
corresponded to expression of Bcl-xL as 
shown in FIGURE 1.
Intensity score 0 Intensity score 1
Intensity score 2 Intensity score 4
TABLE 2 shows comparison of Bcl-
xL protein expression in placenta of severe 
preeclamptic and normotensive group. The 
mean expression of Bcl-xL protein in severe 
preeclamptic group was significantly lower 
than that normotensive group (p=0.00). 
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TABLE 2. The Bcl-xL protein expression (mean ± SD) in placenta of severe preeclamptic and normotensive groups
Variable
Severe 
Preeclamptic 
Group (n=43)
Normotensive 
Group (n=38)
Mean Difference 
(95% CI) p
Bcl-xL Expression 1.29 ± 0.12 1.71 ± 0.14 - 0.42 (-0.47 – -0.36) 0.00
Receiver operating characteristic (ROC) 
analysis was conducted to determine the 
cutoff point of Bcl-xL protein expression. 
The analysis found that the area under curve 
(AUC) was 0.93 or 93% with cutoff point of 
1.495 as shown in FIGURE 2.
FIGURE 2. ROC curve of Bcl-xL protein expression
TABLE 3 shows bivariate analysis 
between independent and dependent variable. 
The pregnant patients with severe preeclampsia 
had more chances to have expression of Bcl-
xL protein valued less than 1.495 compared to 
that normotensive patients, with relative risk 
of 11.78 (3.96-35.01) and p=0.000.
TABLE 3. Bivariate analysis between independent and dependent variable
Variable
Bcl-xL expression
% RR (95% CI) p
<1,495 ≥1,495
Severe preeclamptic group 
Normotensive group
40 
3
3 
35
93.0 
7.9 11.78 (3.96-35.01) 0.000
Bivariate analyses between confounding 
variables and the expression of Bcl-xL protein 
were shown in TABLE 4. Patient’s age did 
not significantly affect the expression of Bcl-
J Med Sci, Volume 50, No. 1, 2018 January: 33-41
38
TABLE 4. Bivariate analyses between confounding variables and expression of Bcl-xL protein
Variables
Bcl-xL expression
% RR (95% CI) p
<1,495 ≥1,495
Patient’s Age 
<20 and >40 years old 
20-40 years old
7 
36
7 
31
50 
54
0.93 
(0.03-31.7)
>0.05
Gestational Age 
≥37 weeks 
<37 weeks
18 
25
35 
3
34 
89
0.38 
(0.25-0.58)
<0.001
Mean Arterial Pressure (MAP) 
>123 mmHg 
≤123 mmHg
24 
19
2 
36
92.3 
34.5
2.67 
(1.83-3.91)
<0.001
Xl protein [RR= 0.93 (0.03-31.7); p >0.05]. 
In contrary, gestational age and MAP affected 
the expression of Bcl-Xl protein (RR =0.38 
(0.25-0.58; p<0.001) and [RR= 2.67 (1.83-
3.91); p<0.001], respectively.
Multivariate analysis using logistic 
regression between independent variable, 
dependent variable, and confounding variable 
is shown in TABLE 5. Diagnosis of severe 
preeclampsia consistently affected the 
expression of Bcl-xL protein (p=0.000), while 
gestational age and MAP did not affect the 
expression of Bcl-xL protein (p>0.05). 
TABLE 5.  Multivariate analysis using logistic regression between independent variable, dependent 
variable, and confounding variable
Variables OR 95% CI p
Diagnosis of severe preeclampsia 
Patient’s age 
Gestational age 
Mean arterial pressure
220,036 
2.63 
1.219 
0.94
14.62-66.12 
0.286-24.260 
0.101-14.728 
0.072-12.301
0.000 
0.393 
0.876 
0.965
DISCUSSION
No significantly different in patient’s 
age between severe preeclamptic group 
and normotensive group was found in this 
study. Previous studies reported that women 
with severe preeclampsia were older than 
normotensive pregnancy although it was 
not statistically significant.5-7 Meanhwile, 
other studies found that preeclampsia were 
more common in women with advanced 
maternal age (≥35 years old) compared to 
younger women. Advanced maternal age is an 
independent risk factor for adverse outcomes 
in first-time mothers with preeclampsia.8, 9
Mean gestational age in severe 
preeclamptic group was significantly lower 
than normotensive group indicating an 
inhomogenous distribution in research 
samples. This result was in accordance with a 
study by Zhang et al.7 which found that mean 
gestasional age in severe preeclamptic group 
was significantly lower than control group. 
On the contrary, Sharp et al.6 and Allaire et 
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al.10 found no difference in gestasional age 
between preeclamptic group and control 
group.
This study also found that MAP in 
severe preeclamptic group was higher than in 
normotensive group. This could be understood 
clearly because in preeclampsia there will be 
an increase in blood pressure.
This study found that expression of 
Bcl-xL protein as antiapoptotic molecule 
in patients with preeclampsia was lower 
than normotensive patients. This was in 
accordance with a study by Shu et al.11 which 
found that Bcl-xL expression was down-
regulated in preterm preeclampsia, but not 
in term preeclampsia and controls. Allaire et 
al.10 concluded that the presence of apoptotic 
marker could be used as a sign of intrauterine 
hypoxia. Hung et al.12 found that hypoxia and 
prolonged hypoxia-reoxigenation seemed to 
cause more reduction in the levels of Bcl-xL, 
although the difference was not statistically 
significant. Meanwhile, a study by Zhang 
et al.7 found that Bcl-xL mRNA expression 
levels was unchanged in severe preeclamptic 
placentas when compared to control. In 
contrast, Whitehead et al.13 found significantly 
increased placental RNA expression of Bcl-xL 
in early onset FGR (fetal growth restriction), 
PE complicated by FGR, and PE without FGR 
compared with preterm controls. This perhaps 
reflects a disordered regulation of apoptosis in 
placental dysfunction that is as yet not clearly 
understood.
No correlation between maternal age and 
expression of Bcl-xL protein as antiapoptotic 
molecule was observed in this stuudy. In 
contrast, Kavathia et al.14 reported that there 
was a positive linear correlation between 
apoptosis and person’s age. The discrepancy 
could be caused by group arrangement in 
this study which was based on risk factor of 
preeclampsia, where patient with age<20 
years old and >40 years old were considered 
in high risk, and patient between 20-40 years 
old were in low risk.
This study also found that there was 
a correlation between gestational age and 
expression of Bcl-xL protein. In normal 
condition, apoptotic activity is increasing 
with gestational age. Previous study by 
Smith et al.15 which compared apoptosis in 
normotensive pregnant women from first 
trimester and third trimester found that there 
was an increase in apoptosis index in third 
trimester. In normal condition, antiapoptotic 
expression is decreasing with gestational age 
as shown in a study by Kim et al.16 which found 
that that there was a decrease in expression 
of Bcl-2 protein, an antiapoptic molecule, in 
third trimester.
Abnormality in apoptosis stimulation in 
patients with essential hypertension showed 
that antiapoptotic factors concentration in 
those patients were decreased and it could be 
caused by ischemia.17 This was in accordance 
with this study where bivariate analysis 
between MAP and expression of Bcl-xL found 
that patients with MAP≥123 mmHg had 2.67 
increases in probability to have expression 
of Bcl-xL <1.50 compared to patients with 
MAP<123 mmHg.
CONCLUSIONS
In conclusion, this study found that 
expression of Bcl-xL protein is lower in 
pregnancy complicated by severe preeclampsia 
compared to normotensive pregnancy. In 
addition, diagnosis of severe preeclampsia 
consistently affect in the expression of Bcl-xL 
protein.
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